期刊文献+

受体酪氨酸激酶Eph基因在甲状腺癌中表达及作用的研究进展 被引量:1

Research progress on the expression and function of receptor tyrosine kinase Eph gene in thyroid carcinoma
下载PDF
导出
摘要 甲状腺肿瘤是一种最常见的内分泌肿瘤,近年流行病学研究表明其发病率呈快速上升趋势。促红细胞生成素产生肝细胞(Eph)基因作为最大的酪氨酸激酶受体家族,被发现参与多种生理病理过程,并且其在肿瘤发生中的作用引起越来越多的关注。Eph受体在人类许多恶性肿瘤中有过表达现象,与肿瘤的生长、侵袭、转移和血管生成有关。研究发现,受体Eph在甲状腺癌中的表达水平明显增加,其在甲状腺癌的发生、发展和侵袭转移中起着重要作用,在甲状腺癌的早期诊断和靶向治疗方面前景广阔。 Thyroid tumor is one of the most common endocrine tumors.Recent epidemiological studies show that the incidence of thyroid carcinoma is increasing rapidly.Erythropoietin producing hepatocyte(Eph) gene as the largest family of tyrosine kinase receptors,is found to be involved in many physiological and pathological processes,and its role in tumorigenesis is attracting more and more attention.Eph receptors are over-expressed in many human malignancies and are associated with tumor growth,invasion,metastasis,and angiogenesis.Research shows that the expression level of Eph receptor in thyroid carcinoma is significantly increased,which plays an important role in the occurrence,development and metastasis of thyroid carcinoma and has broad prospects for early diagnosis and treatment of thyroid carcinoma.
出处 《临床肿瘤学杂志》 CAS 2017年第12期1139-1142,共4页 Chinese Clinical Oncology
基金 国家自然基金资助项目(81371611) 安徽省科技攻关资助项目(1501041160)
关键词 甲状腺癌 促红细胞生成素产生肝细胞(Eph) 靶向治疗 Thyroid carcinoma Erythropoietin producing hepatocyte (Eph) Targeted therapy
  • 相关文献

参考文献2

二级参考文献31

  • 1Dana M. Brantley-Sieders.Clinical relevance of Ephs and ephrins in cancer: Lessons from breast, colorectal, and lung cancer profiling[J].Seminars in Cell and Developmental Biology.2011(1)
  • 2Maria Genander,Jonas Frisén.Ephrins and Eph receptors in stem cells and cancer[J].Current Opinion in Cell Biology.2010(5)
  • 3Hui Miao,Bingcheng Wang.Eph/ephrin signaling in epithelial development and homeostasis[J].International Journal of Biochemistry and Cell Biology.2008(4)
  • 4Anais Malpica,Michael T Deavers,Karen Lu,Diane C Bodurka,Edward N Atkinson,David M Gershenson,Elvio G Silva.Grading Ovarian Serous Carcinoma Using a Two-Tier System[J].The American Journal of Surgical Pathology.2004(4)
  • 5Farshchian M, Nissinen L, Siljamaki E, et aL EphB2 promotes progression of cutaneous squamous cell carcinoma [ J ]. J Invest Dermatol, 2015,135 (7) .. 1882 - 92.
  • 6Perez-White B E, Getsios S. Eph receptor and Ephrin function in breast, gut, and skin epithelia[J]. Cell Adh Migr, 2014,8(4) .. 327 - 38.
  • 7Kaenel P, Mosimann M, Andres A C. The muhifaceted roles of Eph/Ephrin signaling in breast cancer[ J]. Cell Adh Migr, 2012, 6(2) :138 -47.
  • 8Gucciardo E, Sugiyama N, Lehti K. Eph- and Ephrin-dependent mechanisms in tumor and stem cell dynamics [ J ]. Cell Mol Life Sci, 2014,71 (19) :3685 -710.
  • 9Brantley-Sieders D M, Jiang A, Sarma K, et al. Eph/Ephrin pro-filing in human breast cancer reveals significant associations be- tween expression level and clinical outcome [ J ]. PLoS One, 2011,6(9) :e24426.
  • 10Nagano K, Kanasaki S, Yamashita T, et al. Expression of Eph re- ceptor A10 is correlated with lymph node metastasis and stage pro- gression in breast cancer patients[ J ]. Cancer Med, 2013,2 (6) : 972 - 7.

共引文献11

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部